王者荣耀比赛数据

Amgen traded at $247.69 this Friday September 9th, increasing $2.24 or 0.91 percent since the previous trading session. Looking back, over the last four weeks, Amgen gained 1.75 percent. Over the last 12 months, its price rose by 15.88 percent. Looking ahead, we forecast Amgen to be priced at 235.39 by the end of this quarter and at 215.63 in one year, according to 王者荣耀电竞(江西)积分排榜 global macro models projections and analysts expectations.

Stock Price
247.69
Daily Change
0.91%
Yearly
15.88%

Ok
王者荣耀电竞(江西)积分排榜 members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The 王者荣耀电竞(江西)积分排榜 Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Takeda 3,914.00 29.00 0.75% 4.35%
AbbVie 141.42 0.90 0.64% 32.56%
Agios Pharmaceuticals 34.14 0.14 0.41% -24.44%
ALKERMES 24.01 -0.05 -0.21% -21.33%
Amgen 247.69 2.24 0.91% 15.88%
Astrazeneca 60.85 0.53 0.88% 8.16%
Biogen 211.84 3.86 1.86% -29.34%
Bluebird Bio 7.14 0.03 0.42% -60.07%
BioMarin Pharmaceutical 92.93 -0.08 -0.09% 19.17%
Bristol-Myers Squibb 70.16 0.78 1.12% 11.14%
Coherus Biosciences 10.58 0.06 0.57% -31.25%
Exelixis 17.90 0.09 0.51% -10.32%
Genmab 2,779.00 12.00 0.43% -0.14%
Gilead Sciences 65.28 0.18 0.28% -8.04%
GlaxoSmithKline 1,348.60 4.40 0.33% -5.00%
Glaxosmithkline 31.89 0.38 1.21% -19.77%
Intercept Pharmaceuticals 17.00 -0.13 -0.76% 16.04%
Incyte Corp 72.20 0.48 0.67% 1.52%
Ionis Pharmaceuticals 46.84 2.57 5.81% 29.79%
J&J 165.71 0.32 0.19% -0.75%
Eli Lilly 317.70 2.20 0.70% 32.65%
Merck & Co 87.34 -0.08 -0.09% 18.91%
Moderna Inc 142.28 1.00 0.71% -68.34%
Mirati Therapeutics 84.77 0.42 0.50% -48.81%
Neurocrine Biosciences 106.51 -0.17 -0.16% 10.10%
Novartis 79.36 0.58 0.74% 0.88%
Novartis 82.60 1.34 1.65% -3.31%
Puma Biotechnology 2.74 0.18 7.03% -61.62%
Pfizer 47.84 0.76 1.61% 4.94%
PTC Therapeutics 53.64 -0.21 -0.39% 28.33%
Ultragenyx Pharmaceutical 49.24 1.51 3.16% -51.58%
Regeneron Pharmaceuticals 724.32 15.47 2.18% 11.35%
Roche Holding 324.25 0.40 0.12% -5.74%
Sanofi 81.20 0.64 0.79% -0.82%
Seattle Genetics 155.47 2.83 1.85% 2.61%
Sarepta Therapeutics 118.44 -0.80 -0.67% 47.19%
Teva Pharmaceutical Industries Ltd 3,040.00 41.00 1.37% 1.10%
Vertex Pharmaceuticals 292.11 3.12 1.08% 54.91%

Indexes Price Day Year
US500 4067 61.18 1.53% -8.77%
USND 12112 250.18 2.11% -19.87%
USNDX 12588 267.10 2.17% -18.47%
US30 32152 377.19 1.19% -7.10%

Amgen
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.